How Tech and Robotics Are Helping Fight Ebola

The video discusses the longstanding capability to produce experimental drugs and the high costs associated with clinical trials, particularly phase three trials. It highlights the challenges in developing an Ebola vaccine due to funding cuts and lack of commercial interest. The video also covers current efforts to produce Ebola treatments and vaccines, emphasizing the urgency due to potential outbreak scenarios. Technological innovations, such as screening technologies, are also explored as tools to aid in Ebola diagnosis and management.

How has military funding influenced the development of the Z map for Ebola?

What are the main reasons for the delays in conducting clinical trials for Ebola treatments?

What challenges did the NIH face in developing a vaccine for Ebola?

What are the expected outcomes of ramping up production of the Z map and other Ebola vaccines?

What is the significance of the FDA's emergency use authorization for the Filmare screening technology?